Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@conference{d9a4e23ae77c4773ad4215095f168d7c,
title = "Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses",
author = "Ternov, {Klara Kvorning} and AB Nols{\o}e and O Bratt and Mikkel Fode and Henriette Lindberg and Kistorp, {Caroline Michaela} and Ganesh Palapattu and Klausen, {Tobias Wirenfeldt} and S{\o}nksen, {Jens Otto Reimers} and {\O}stergren, {Peter Busch}",
year = "2019",
language = "English",
note = "Forskningens Dag ; Conference date: 27-11-2019",

}

RIS

TY - ABST

T1 - Effects of first-line enzalutamide and abiraterone plus prednisone on health-related quality-of-life in men with metastatic castration-resistant prostate cancer: a systematic review and meta-analyses

AU - Ternov, Klara Kvorning

AU - Nolsøe, AB

AU - Bratt, O

AU - Fode , Mikkel

AU - Lindberg, Henriette

AU - Kistorp, Caroline Michaela

AU - Palapattu, Ganesh

AU - Klausen, Tobias Wirenfeldt

AU - Sønksen, Jens Otto Reimers

AU - Østergren , Peter Busch

PY - 2019

Y1 - 2019

M3 - Conference abstract for conference

ER -

ID: 60123539